Hospital-level Variation in the Management of Blood Pressure and Low-density Lipoprotein in the Outpatient Hypertensives in China-a Cross Sectional Study

Hypertension Clinical Trial

Official title:

Survey on BP, Lipids and Cardiovascular Risks in the Outpatient Hypertensives and Continuing Medical Education Program

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT03862183
• Other study ID #: UPPDATE
• Status: Recruiting
• Start date: July 1, 2017
• Est. completion date: December 30, 2020

Study information

• Verified date: March 2019
• Source: Huashan Hospital
• Contact: xiufang gao, PhD
• Phone: +86 13788908071
• Email: sophiakao[@]126.com
• Is FDA regulated: No
• Study type: Observational [Patient Registry]

Clinical Trial Summary

To investigate the proportion, medication use and control rate of metabolic abnormalities such as dyslipidemia in outpatients with hypertension in different levels of hospitals in China. To investigate the gap between guidelines and clinical practices, and analyze the cause. we also set up a continuing medical education program to narrow the gap and the effect of the program will be estimated.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 21000
• Est. completion date: December 30, 2020
• Est. primary completion date: December 30, 2020
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 85 Years

Eligibility

Inclusion Criteria:

1. Outpatients from departments of Cardiology, Endocrinology, Nephrology, Neurology, Geriatrics or General Internal Medicine.

2. Diagnosed as hypertension. Diagnostic criteria: 1)The office BP measured at the day of visit and at least one time before that day were above the cut-off values ( =140 mmHg SBP and/or =90 mmHg DBP); 2)for patients with normal BP at the day of visit, they should have already been given pre-treatment with antihypertensive drugs = 2 weeks.

3. Voluntary participation.

Exclusion Criteria:

1. Patients aged< 18 years old.

2. Patients without a definite diagnosis of hypertension(for instance, if the patient has been taking antihypertensive drugs irregularly, it is difficult to confirm the diagnosis of hypertension).

3. Patients with a definite diagnosis of secondary hypertension.

4. Patients are diagnosed dyslipidemia with clear cause, such as nephrotic syndrome, severe hypothyroidism, terminal stage of malignancy, etc.

5. Patients are diagnosed end-stage renal disease, hemodialysis, and peritoneal dialysis patients.

6. Patients diagnosed with mental abnormalities who are unable to complete the questionnaire.

7. Patients have once participated in this research during this study cycle(to avoid repeated participation).

Related Conditions & MeSH terms

• Hyperlipidemia
• Hyperlipidemias
• Hyperlipoproteinemias
• Hypertension

Intervention

Other:
• continuing medical education program
educating all the involved doctor the same medical knowledge on hypertension control

Locations

Country	Name	City	State
China	Cardiology Department in Huashan Hospital	Shanghai	Shanghai

Sponsors (1)

Lead Sponsor	Collaborator
Huashan Hospital

Country where clinical trial is conducted

China, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	rate of blood pressure goal achievement	systolic blood pressure<140mmHg and diastolic blood pressure<90mmHg	2017-2020